Bioclinica

Bioclinica is a leading global provider of clinical trial services and technology, specializing in medical imaging, cardiac safety, and eClinical solutions. The company provides scientific and technological expertise to pharmaceutical, biotechnology, and medical device organizations to enhance the efficiency and accuracy of clinical research. Its core offerings include centralized medical imaging core lab services, cardiovascular safety monitoring, and electronic Clinical Outcome Assessments (eCOA). In 2021, Bioclinica merged with ERT (eResearchTechnology) to form Clario, creating a powerhouse in the clinical endpoint technology space. The combined entity, Clario, integrates data from devices, sites, and patients to generate high-quality clinical evidence. As of late 2025, the company is in the process of being acquired by Thermo Fisher Scientific to further expand digital capabilities and AI-driven clinical research services.